肿瘤细胞源性外泌体在结直肠癌转移前微环境形成中的作用

摘要/Abstract

摘要：

远处转移是导致晚期结直肠癌患者死亡的主要原因，肿瘤细胞源性外泌体作为信息传递的介质，广泛参与结直肠癌转移前微环境形成的各个环节。深入研究外泌体在转移前微环境形成中的机制，可为结直肠癌的靶向治疗和预测肿瘤进展提供新的思路。

陈洁, 徐红, 陈雨甜. 肿瘤细胞源性外泌体在结直肠癌转移前微环境形成中的作用[J]. 国际肿瘤学杂志, 2024, 51(10): 650-654.

Chen Jie, Xu Hong, Chen Yutian. Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer[J]. Journal of International Oncology, 2024, 51(10): 650-654.

参考文献36

[1]	郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2024,46(3): 221-231. DOI:10.3760/cma.j.cn112152-20240119-00035.
[2]	Herath S, Razavi Bazaz S, Monkman J, et al. Circulating tumor cell clusters: insights into tumour dissemination and metastasis[J].Expert Rev Mol Diagn,2020,20(11): 1139-1147. DOI:10.1080/14737159.2020.1846523. pmid:33140979
[3]	Doglioni G, Parik S, Fendt SM. Interactions in the (Pre)metastatic niche support metastasis formation[J].Front Oncol,2019,9: 219. DOI:10.3389/fonc.2019.00219. pmid:31069166
[4]	Titu S, Gata VA, Decea RM, et al. Exosomes in colorectal cancer: from physiology to clinical applications[J].Int J Mol Sci,2023,24(5): 4382. DOI:10.3390/ijms24054382.
[5]	Liu C, Xia C, Xia C. Biology and function of exosomes in tumor immunotherapy[J].Biomed Pharmacother,2023,169: 115853. DOI:10.1016/j.biopha.2023.115853.
[6]	Tian Y, Cheng C, Wei Y, et al. The role of exosomes in inflammatory diseases and tumor-related inflammation[J].Cells,2022,11(6): 1005. DOI:10.3390/cells11061005.
[7]	Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis[J].Nature,2015,527(7578): 329-335. DOI:10.1038/nature15756.
[8]	Li S, Qu Y, Liu L, et al. Tumour-derived exosomes in liver metastasis: a pandora's box[J].Cell Prolif,2023,56(10): e13452. DOI:10.1111/cpr.13452.
[9]	Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation[J].Nat Commun,2020,11(1): 1211. DOI:10.1038/s41467-020-14869-x. pmid:32139701
[10]	Wang C, Tsai S. Regulation of lymphangiogenesis by extracellular vesicles in cancer metastasis[J].Exp Biol Med (Maywood),2021,246(19): 2048-2056. DOI:10.1177/15353702211021022.
[11]	Sun B, Zhou Y, Fang Y, et al. Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes[J].Int J Cancer,2019,145(6): 1648-1659. DOI:10.1002/ijc.32196. pmid:30734278
[12]	Hu H, Yu C, Zhang H, et al. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2[J].Int J Biol Macromol,2019,132: 470-477. DOI:10.1016/j.ijbiomac.2019.03.221.
[13]	He Q, Ye A, Ye W, et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1[J].Cell Death Dis,2021,12(6): 576. DOI:10.1038/s41419-021-03803-8. pmid:34088891
[14]	Dokhanchi M, Pakravan K, Zareian S, et al. Colorectal cancer cell-derived extracellular vesicles transfer miR-221-3p to promote endothelial cell angiogenesis via targeting suppressor of cytokine signaling 3[J].Life Sci,2021,285: 119937. DOI:10.1016/j.lfs.2021.119937.
[15]	Shang A, Wang X, Gu C, et al. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1[J].Aging (Albany NY),2020,12(9): 8352-8371. DOI:10.18632/aging.103145.
[16]	Chen C, Liu Y, Liu L, et al. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway[J].J Exp Clin Cancer Res,2023,42(1): 46. DOI:10.1186/s13046-023-02619-y. pmid:36793126
[17]	Hu G, Lin C, Gao K, et al. Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating Smad2/3 pathway in colorectal cancer[J].Mol Med,2023,29(1): 155. DOI:10.1186/s10020-023-00747-x. pmid:37940881
[18]	Li Y, Jiang D, Zhang Z, et al. Colorectal cancer cell-secreted exosomal miRNA N-72 promotes tumor angiogenesis by targeting CLDN18[J].Am J Cancer Res,2023,13(8): 3482-3499. pmid:37693144
[19]	Dou R, Liu K, Yang C, et al. EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer[J].Clin Transl Med,2021,11(12): e595. DOI:10.1002/ctm2.595. pmid:34936736
[20]	Jiang K, Chen H, Fang Y, et al. Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness[J].J Exp Clin Cancer Res,2021,40(1): 21. DOI:10.1186/s13046-020-01816-3. pmid:33413536
[21]	Zhao S, Mi Y, Guan B, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer[J].J Hematol Oncol,2020,13(1): 156. DOI:10.1186/s13045-020-00991-2.
[22]	Chen C, Yao X, Xu Y, et al. Dahuang zhechong pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche[J].J Ethnopharmacol,2019,238: 111878. DOI:10.1016/j.jep.2019.111878.
[23]	Liang Z, Liu H, Wang F, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J].Cell Death Dis,2019,10(11): 829. DOI:10.1038/s41419-019-2077-0.
[24]	Wang D, Wang X, Si M, et al. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J].Cancer Lett,2020,474: 36-52. DOI:10.1016/j.canlet.2020.01.005. pmid:31931030
[25]	Pei W, Wei K, Wu Y, et al. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization[J].Gene,2023,885: 147692. DOI:10.1016/j.gene.2023.147692.
[26]	Furumaya C, Martinez-Sanz P, Bouti P, et al. Plasticity in pro- and anti-tumor activity of neutrophils: shifting the balance[J].Front Immunol,2020,11: 2100. DOI:10.3389/fimmu.2020.02100. pmid:32983165
[27]	Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis[J].Mol Cancer,2020,19(1): 117. DOI:10.1186/s12943-020-01235-0.
[28]	Sun H, Meng Q, Shi C, et al. Hypoxia-inducible exosomes facilitate liver-tropic premetastatic niche in colorectal cancer[J].Hepatology,2021,74(5): 2633-2651. DOI:10.1002/hep.32009.
[29]	Huang Y, Luo Y, Ou W, et al. Exosomal lncRNA SNHG10 derived from colorectal cancer cells suppresses natural killer cell cytotoxicity by upregulating INHBC[J].Cancer Cell Int,2021,21(1): 528. DOI:10.1186/s12935-021-02221-2. pmid:34641864
[30]	Hu X, Lin Z, Wang Z, et al. Emerging role of PD-L1 modification in cancer immunotherapy[J].Am J Cancer Res,2021,11(8): 3832-3840. pmid:34522452
[31]	Xian D, Niu L, Zeng J, et al. LncRNA KCNQ1OT1 secreted by tumor cell-derived exosomes mediates immune escape in colorectal cancer by regulating PD-L1 ubiquitination via miR-30a-5p/USP22[J].Front Cell Dev Biol,2021,9: 653808. DOI:10.3389/fcell.2021.653808.
[32]	Sun W, Cui J, Ge Y, et al. Tumor stem cell-derived exosomal microRNA-17-5p inhibits anti-tumor immunity in colorectal cancer via targeting SPOP and overexpressing PD-L1[J].Cell Death Discov,2022,8(1): 223. DOI:10.1038/s41420-022-00919-4. pmid:35461336
[33]	Poggio M, Hu TY, Pai CC, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory[J].Cell,2019,177(2): 414-427.e13. DOI:10.1016/j.cell.2019.02.016. pmid:30951669
[34]	Yuan Z, Li Y, Zhang S, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments[J].Mol Cancer,2023,22(1): 48. DOI:10.1186/s12943-023-01744-8. pmid:36906534
[35]	Tian F, Wang P, Lin D, et al. Exosome-delivered miR-221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer[J].Cancer Sci,2021,112(9): 3744-3755. DOI:10.1111/cas.15028.
[36]	Kamerkar S, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity[J].Sci Adv,2022,8(7): eabj7002. DOI:10.1126/sciadv.abj7002.

肿瘤细胞源性外泌体在结直肠癌转移前微环境形成中的作用

Role of tumor cell-derived exosomes in the pre-metastatic niche formation in colorectal cancer

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献36

相关文章15

编辑推荐

Metrics

本文评价

[1]	韦伟, 蔡曌颖, 钱亚云.通关藤联合XELOX方案促进人结直肠癌HCT116细胞双硫死亡的作用[J]. 国际肿瘤学杂志, 2024, 51(9): 545-555.
[2]	詹海峰, 王文学, 耿嘉蔚.晚期结直肠癌精准分子靶向治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(9): 601-605.
[3]	李志伟, 翟春宝.中药多酚类成分抗结直肠癌作用研究进展[J]. 国际肿瘤学杂志, 2024, 51(8): 526-531.
[4]	孟繁明.伊尼妥单抗联合卡培他滨治疗曲妥珠单抗经治的HER2阳性晚期乳腺癌1例[J]. 国际肿瘤学杂志, 2024, 51(8): 538-541.
[5]	刘琴, 张强强, 杨继元, 胡艳.晚期前列腺癌双侧乳腺和腋窝淋巴结转移1例[J]. 国际肿瘤学杂志, 2024, 51(7): 478-480.
[6]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[7]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[8]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[9]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[10]	傅旖, 马辰莺, 张露, 周菊英.生境分析在恶性肿瘤影像组学中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(5): 292-297.
[11]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[12]	李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵.寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174.
[13]	刘博翰, 黄俊星.液体活检技术在食管鳞状细胞癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 105-108.
[14]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[15]	何佩霈, 杨朝凤, 李杨.肝癌肿瘤微环境与消融治疗的研究现状与展望[J]. 国际肿瘤学杂志, 2024, 51(10): 655-659.